Literature DB >> 16621396

Indirect magnetic resonance lymphangiography in patients with lymphedema preliminary results in humans.

Christian Lohrmann1, Etelka Foeldi, Mathias Langer.   

Abstract

PURPOSE: To assess the feasibility of indirect magnetic resonance (MR) lymphangiography with intracutaneous injection of gadodiamide, a commercially available, non-ionic, extracellular paramagnetic contrast agent for the detection of lymphatic vessels in patients with lymphedema.
MATERIALS AND METHODS: In 2005, three patients with lymphedema of the lower extremities (1 primary, 2 secondary) were referred by the Foeldi Clinic for Lymphology for indirect magnetic resonance lymphangiography. 4.5 mL of gadodiamide and 0.5 mL of mepivacainhydrochloride 1% were injected intracutaneously into the dorsal aspect of each foot. MR imaging was performed with a 1.5-T system equipped with high-performance gradients. For indirect magnetic resonance lymphangiography, a 3D Fast Low Angle Shot (FLASH) sequence (TR/TE: 5.1/1.23; flip angle: 25; matrix: 448 x 448; bandwidth: 330 Hz/pixel; 6/8 rectangular field of view with a maximum dimension of 500 mm; slices: 88; voxel size: 2.0 mm x 1.0 mm x 1.0mm; acquisition time: 0 min 31 s) was used.
RESULTS: Indirect magnetic resonance lymphangiography depicted lymphatic vessels of the lower and upper leg, and inguinal lymph nodes in all three patients. After 5 min of contrast material application, concomitant venous enhancement was detected. Collateral vessels with dermal back-flow were seen in two patients. A lymphocele in the inguinal region with the afferent lymphatic vessel was depicted in one patient.
CONCLUSION: In the presented small study group, indirect magnetic resonance lymphangiography was technically feasible, and no complications were observed after intracutaneous injection of gadodiamide. Visualizing the lymphatic vessels and accompanying complications non-invasively and without the use of radiation, the presented method has the capability to become a routine diagnostic imaging tool in patients with primary and secondary lymphedema. The method is not able to characterize lymph node morphology, but could provide additional information about the lymphatic vessels when lymph nodes are examined, e.g. with super-paramagnetic iron oxide particles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621396     DOI: 10.1016/j.ejrad.2006.02.012

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  High-resolution MR lymphangiography for planning lymphaticovenous anastomosis treatment: a single-centre experience.

Authors:  Maria Antonietta Mazzei; Francesco Gentili; Francesco Giuseppe Mazzei; Paolo Gennaro; Duccio Guerrieri; Andrea Nigri; Guido Gabriele; Elisabetta Weber; Alfonso Fausto; Giuseppe Botta; Luca Volterrani
Journal:  Radiol Med       Date:  2017-08-02       Impact factor: 3.469

Review 2.  New horizons for imaging lymphatic function.

Authors:  Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 3.  Application of imaging in lymphedema surgical therapies.

Authors:  Xingyi Du; Chunjun Liu
Journal:  Gland Surg       Date:  2020-04

Review 4.  Bridging the divide between pathogenesis and detection in lymphedema.

Authors:  J Brandon Dixon; Michael J Weiler
Journal:  Semin Cell Dev Biol       Date:  2014-12-26       Impact factor: 7.727

Review 5.  Imaging of the Lymphatic Vessels for Surgical Planning: A Systematic Review.

Authors:  Saskia van Heumen; Jonas J M Riksen; Wichor M Bramer; Gijs van Soest; Dalibor Vasilic
Journal:  Ann Surg Oncol       Date:  2022-09-28       Impact factor: 4.339

Review 6.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 7.  Development and Themes of Diagnostic and Treatment Procedures for Secondary Leg Lymphedema in Patients with Gynecologic Cancers.

Authors:  Yumiko Watanabe; Masafumi Koshiyama; Keiko Seki; Miwa Nakagawa; Eri Ikuta; Makiko Oowaki; Shin-Ichi Sakamoto
Journal:  Healthcare (Basel)       Date:  2019-08-27

8.  MR lymphography of lymphatic vessels in lower extremity with gynecologic oncology-related lymphedema.

Authors:  Qing Lu; Zachary Delproposto; Alice Hu; Christine Tran; Ningfei Liu; Yulai Li; Jianrong Xu; Duy Bui; Jiani Hu
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Systematic Review of Magnetic Resonance Lymphangiography From a Technical Perspective.

Authors:  Michael Mills; Malou van Zanten; Marco Borri; Peter S Mortimer; Kristiana Gordon; Pia Ostergaard; Franklyn A Howe
Journal:  J Magn Reson Imaging       Date:  2021-02-24       Impact factor: 4.813

10.  In Vitro Studies Regarding the Safety of Chitosan and Hyaluronic Acid-Based Nanohydrogels Containing Contrast Agents for Magnetic Resonance Imaging.

Authors:  Cecilia Virginia Gheran; Sorina Nicoleta Voicu; Bianca Galateanu; Maité Callewaert; Juliette Moreau; Cyril Cadiou; Françoise Chuburu; Anca Dinischiotu
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.